Sublingual Immunotherapy

Otolaryngologic Clinics of North America

Volumn 44, Issue 3, 2011, Pages 753-764

  Lin, Sandra Y ^a   Leatherman, Bryan ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nose and Throat Associates   (United States)

Author keywords

Allergen specific immunotherapy; Allergic rhinitis; Asthma; Subcutaneous immunotherapy; Sublingual immunotherapy

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; POLLEN EXTRACT; RAGWEED ANTIGEN; TIMOTHY GRASS ANTIGEN; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ALLERGY; ANAPHYLAXIS; ANTIBODY PRODUCTION; ASTHMA; CLINICAL TRIAL (TOPIC); DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; META ANALYSIS (TOPIC); PHLEUM PRATENSE; REVIEW; RHINOCONJUNCTIVITIS; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW (TOPIC);

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 79957461559     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2011.03.012     Document Type: Review

References (62)

1. Howarth P.H. Is allergy increasing?-early life influences. Clin Exp Allergy 1998, 28(Suppl 6):2-7.
2. Bellanti J.A., Wallerstedt D.B. Allergic rhinitis update: epidemiology and natural history. Allergy Asthma Proc 2000, 21(6):367-370.
3. Nathan R.A. The burden of allergic rhinitis. Allergy Asthma Proc 2007, 28(1):3-9.
4. Durham S.R., Walker S.M., Varga E.M., et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999, 341:468-475.
5. Purello-D'ambrosio F., Gangemi S., Merendino R.A., et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001, 31:1295-1302.
6. Polosa R., Al-Delaimy W.K., Russo C., et al. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res 2005, 6:153.
7. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334.
8. Lockey R. Adverse skin reactions associated with skin testing and immunotherapy. Allergy Proc 1995, 16(6):292-296.
9. Canonica G.W., Passalcqua A.G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003, 111:437-448.
10. Medicines CotSo. CMS update: desensitizing vaccines. Br Med J 1986, 292:984.
11. Scadding G.K., Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986, 16:483-491.
12. Bousquet J., Lockey R., Maling H. World Health Organization Position paper: allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998, 53:1-14.
13. Malling H., Abreu-Noguera J., Alvarez-Cuesta E., et al. EAACI/EXPACI position paper on local immunotherapy. Allergy 1998, 53:933-944.
14. Bagnosco M., Mariani G., Passalacqu G., et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 1997, 100:122-129.
15. Lima M., Wilson D., Pitkin L., et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002, 32:507-514.
16. Marcucci F., Sensi L., Frate F., et al. Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. Allergy 2001, 56:1091-1095.
17. Passalacqua G., Albano M., Fregonese L., et al. Randomized controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998, 351:629-632.
18. Ippoliti F., De Santis W., Volterrani A., et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003, 14:216-221.
19. Sanchez Palacios A., Shcamann F., Garcia J.A. Sublingual immunotherapy with cat epithelial extract. Personal experience. Allergol Immunopathol (Madr) 2001, 29:60-65.
20. Durham S.R., Yang W.H., Pedersen M.R., et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006, 117:802-809.
21. Bahceciler N.N., Arikan C., Taylor A., et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites. Int Arch Allergy Immunol 2005, 136:287-294.
22. Bufe A., Aiegler-Kirbach E., Stoeckmann E., et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004, 59:498-504.
23. La Rosa M., Ranno C., Andre C., et al. Double blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999, 104:425-432.
24. Smith H., White P., Annila I., et al. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004, 114(4):831-837.
25. Tonnel A.B., Sherperrl A., Douay B., et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004, 59:491-497.
26. Tari M.G., Mancino M., Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol (Madr) 1990, 18:277-284.
27. Tari M.G., Mancino M., Madonna F., et al. Immunologic evaluation of 24 month course of sublingual immunotherapy. Allergol Immunopathol (Madr) 1994, 22(5):209-216.
28. Wilson D.R., Torres L.I., Durham S.R. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003, 2. CD002893.
29. Cox L.S., Linnemann D.L., Nolte H., et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006, 117:1021-1035.
30. Calamita Z., Saconato H., Pela A.G., et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006, 62(10):1162-1172.
31. Penangos M., Compalati E., Tarantini F., et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006, 97(2):141-148.
32. Larenas-Linnemann D. Subcutaneous and sublingual immunotherapy in children: complete update on controversies, dosing, and efficacy. Curr Allergy Asthma Rep 2008, 8(6):465-474.
33. Novembre E., Galli E., Landi F., et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjuntivitis. J Allergy Clin Immunol 2004, 114(4):851-857.
34. Marogna M., Tomassetti D., Bernasconi A., et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008, 101(2):206-211.
35. Di Rienzo V., Marcucci F., Puccinelli P., et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10 year prospective study. Clin Exp Allergy 2003, 33(2):206-210.
36. Wahn U., Tabar A., Kuna P., et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009, 123(1):160-166.
37. Bufe A., Eberle P., Franke-Beckmann E., et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009, 123(1):167-173.
38. Wise S.K., Woody J., Koepp S., et al. Quality of life outcomes with sublingual immunotherapy. Am J Otolaryngol 2009, 30(5):305-311.
39. Ciprandi G., Cadario G., Valle C., et al. Sublingual immunotherapy in polysensitized patients: effect on quality of life. J Investig Allergol Clin Immunol 2010, 20(4):274-279.
40. Quirino T., Iemoli E., Seciliana E., et al. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996, 26:1253-1261.
41. Mungan D., Misirligil Z., Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma-a placebo controlled study. Ann Allergy Asthma Immunol 1999, 82:485-490.
42. Bernadis P., Agnoletto M., Puccinelli P., et al. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immuno 2000, 10:142-148.
43. Kinchi M.S., Poulsen L.K., Carat F., et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized placebo-controlled, double blind, double dummy study. Allergy 2004, 59:45-53.
44. Eifan A.O., Keles S., Bahceciler N.N., et al. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy 2007, 62:567-568.
45. de Groot H., Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009, 64(6):963-964.
46. Dunsky E.H., Goldstein M.F., Dvorin D.J., et al. Anaphylaxis to sublingual immunotherapy. Allergy 2006, 61:1235.
47. Esch R.E., Bush R.K., Peden D., et al. Sublingual-oral administration of standardized allergenic extracts: phase I safety and dosing results. Ann Allergy Asthma Immunol 2008, 100:475-481.
48. Hansel F.K., Anderson J.R. Allergy in otolaryngology. Am Acad Ophthalmol Otolaryngol 1959, 186. (American Academy of Ophthalmology and Otolaryngology Home Study Courses, Section on Instruction).
49. Larenas-Linnemann D., Cox L.S., Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008, 100(2):137-145.
50. Cox L., Li J.T., Nelson H., et al. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007, 120:S25-S85.
51. Frati F., La Grutta S., Bernardini R., et al. Sublingual immunotherapy: administration, dosages, use. Int J Immunopathol Pharmacol 2009, 22(Suppl 4):13-16.
52. Sambugaro R., Puccinelli P., Burastero S.E., et al. The efficacy of sublingual immunotherapy for respiratory allergy is not affected by different dosage regimens in the induction phase. Allergol Immunopathol (Madr) 2003, 31:329-337.
53. Leatherman B.D., Owen S., Parker M., et al. Sublingual immunotherapy: past, present, paradigm for the future? a review of the literature. Otolaryngol Head Neck Surg 2007, 136:S1-S20.
54. Skoner D., Gentile D., Bush R., et al. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen. J Allergy Clin Immunol 2010, 125(3):660-666.
55. Blaiss M., Maloney J., Nolte H., et al. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol 2011, 127(1):64-71. e1-4.
56. Nelson H.S., Nolte H., Creticos P., et al. Efficacy and Safety of Timothy Grass Allergy Immunotherapy Tablet (AIT) in North American Adults. J Allergy Clin Immunol 2011, 127(1):72-80. e1, e2.
57. Ott H., Sieber J., Brehler R., et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009, 64(1):179-186.
58. Cadario G., Ciprandi G., Larosa M., et al. Comparison between continuous or intermittent schedules of sublingual immunotherapy for house dust mites: effects on compliance, patient satisfaction, quality of life and safety. Int J Immunopathol Pharmacol 2008, 21(2):471-473.
59. Sieber J., Koberlein J., Mosges R. Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules-IPD meta-analysis. Curr Med Res Opin 2010, 26(4):925-932.
60. Durham S.R., Emminger W., Kapp A., et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010, 125(1):131-138.
61. Canonica G.W., Bousquet J., Casale T., et al. Sub-lingual immunotherapy world allergy organization position paper 2009. Allergy 2009, 64(Suppl 91):1-59.
62. Alvarez-Cuesta E., Bousquet J., Canonica G.W., et al. Standards for practical allergen-specific immunotherapy. Allergy 2006, 61(Suppl 82):1-20.